CG Oncology Announces $105 Million Oversubscribed Crossover Financing to Support Continued Advancement of Clinical-Stage Bladder Cancer Pipeline

CG Oncology

related news
Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats up

Reuters

April 18 2026
Pfizer Ventures gets behind OTR Therapeutics’s $100M series A to boost R&D hub’s capability

Fierce Biotech

December 05 2025

Get In Touch

Contact Us